Phase 1 multicenter, dose-expansion study of ARX788 as monotherapy in HER2-positive advanced gastric and gastroesophageal junction adenocarcinoma
Yang Zhang(Guangdong Testing Institute for Product Quality Supervision), Rui‐Hua Xu(Sun Yat-sen University), Gao-Zhun Xiong, Qi Zhao(Academy of Medical Sciences), Ao Shen(Sun Yat-sen University), Yanqiao Zhang(Harbin Medical University), Miao‐Zhen Qiu(Sun Yat-sen University), Xuejun Liang, Tao� Zhang(Ningbo University), Xiaoli Wei(Anhui Medical University), Jufeng Wang(Henan Cancer Hospital), Yanping Ji, Gang Xia(World Vision), Hongyun Zhao(Sun Yat-sen University), Xianglin Yuan(Tongji University), De‐Shen Wang(Sun Yat-sen University)
Cited by 51
Related Papers
Circular RNA: metabolism, functions and interactions with proteins
|Molecular Cancer|2020|1.6k
IBS: an illustrator for the presentation and visualization of biological sequences
|Bioinformatics|2015|1.1k
METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma
|Molecular Cancer|2019|868
Erythrocyte–Platelet Hybrid Membrane Coating for Enhanced Nanoparticle Functionalization
|Advanced Materials|2017|756